448
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL INVESTIGATION

What to expect from a third step in treatment resistant depression: A prospective open study on escitalopram

, , , , , , , , , , , , , & show all
Pages 472-482 | Received 12 Feb 2014, Accepted 11 Nov 2014, Published online: 23 Dec 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lucie Bartova, Markus Dold, Alexander Kautzky, Chiara Fabbri, Marie Spies, Alessandro Serretti, Daniel Souery, Julien Mendlewicz, Joseph Zohar, Stuart Montgomery, Alexandra Schosser & Siegfried Kasper. (2019) Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice. The World Journal of Biological Psychiatry 20:6, pages 427-448.
Read now

Articles from other publishers (13)

Francesca Regen. 2023. Praxishandbuch Depression. Praxishandbuch Depression 165 176 .
Markku Lähteenvuo, Heidi Taipale, Antti Tanskanen, Saara Rannanpää & Jari Tiihonen. (2022) Courses of treatment and risk factors for treatment-resistant depression in Finnish primary and special healthcare: A nationwide cohort study. Journal of Affective Disorders 308, pages 236-242.
Crossref
Inara Fernanda Misiuta Raupp-Barcaro, Isabella Caroline da Silva Dias, Erika Meyer, Jeane Cristina Fonseca Vieira, Giovana da Silva Pereira, Arthur Ribeiro Petkowicz, Rúbia Maria Weffort de Oliveira & Roberto Andreatini. (2021) Involvement of dopamine D2 and glutamate NMDA receptors in the antidepressant-like effect of amantadine in mice. Behavioural Brain Research 413, pages 113443.
Crossref
Chiara Fabbri, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Diego Albani, Gianluigi Forloni, Panagiotis Ferentinos, Dan Rujescu, Julien Mendlewicz, Alessandro Serretti & Cathryn M. Lewis. (2021) Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression. Journal of Affective Disorders 279, pages 722-729.
Crossref
Stefano Porcelli, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Panagiotis Ferentinos, Dan Rujescu, Julien Mendlewicz, Emilio Merlo Pich, Stephane Pollentier, Brenda W.J.H. Penninx & Alessandro Serretti. (2020) Social dysfunction in mood disorders and schizophrenia: Clinical modulators in four independent samples. Progress in Neuro-Psychopharmacology and Biological Psychiatry 99, pages 109835.
Crossref
Paolo Olgiati, Alessandro Serretti, Daniel Souery, Siegfried Kasper, Christoph Kraus, Stuart Montgomery, Joseph Zohar & Julien Mendlewicz. (2019) Attrition in treatment-resistant depression. International Clinical Psychopharmacology 34:4, pages 161-169.
Crossref
Laura Mandelli, Alessandro Serretti, Daniel Souery, Julien Mendlewicz, Siegfried Kasper, Stuart Montgomery & Joseph Zohar. (2019) High occupational level is associated with poor response to the treatment of depression: A replication study. European Neuropsychopharmacology 29:3, pages 349-355.
Crossref
A. Kautzky, M. Dold, L. Bartova, M. Spies, G. S. Kranz, D. Souery, S. Montgomery, J. Mendlewicz, J. Zohar, C. Fabbri, A. Serretti, R. Lanzenberger, D. Dikeos, D. Rujescu & S. Kasper. (2019) Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study. Acta Psychiatrica Scandinavica 139:1, pages 78-88.
Crossref
Marco Calabrò, Chiara Fabbri, Concetta Crisafulli, Diego Albani, Gianluigi Forloni, Siegfried Kasper, Antonina Sidoti, Elvira Velardi, Joseph Zohar, Alzbeta Juven-Wetzler, Daniel Souery, Stuart Montgomery, Julien Mendlewicz & Alessandro Serretti. (2018) The serotonin transporter and the activity regulated cytoskeleton-associated protein genes in antidepressant response and resistance: 5-HTTLPR and other variants. Human Psychopharmacology: Clinical and Experimental 33:6, pages e2682.
Crossref
Chiara Fabbri, Filippo Corponi, Diego Albani, Ilaria Raimondi, Gianluigi Forloni, Koen Schruers, Siegfried Kasper, Alexander Kautzky, Joseph Zohar, Daniel Souery, Stuart Montgomery, Carlotta Pia Cristalli, Vilma Mantovani, Julien Mendlewicz & Alessandro Serretti. (2018) Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance. Progress in Neuro-Psychopharmacology and Biological Psychiatry 81, pages 203-210.
Crossref
Paolo Olgiati, Alessandro Serretti, Daniel Souery, Markus Dold, Siegfried Kasper, Stuart Montgomery, Joseph Zohar & Julien Mendlewicz. (2018) Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression. Journal of Affective Disorders 227, pages 777-786.
Crossref
Chiara Fabbri, Concetta Crisafulli, Raffaella Calati, Diego Albani, Gianluigi Forloni, Marco Calabrò, Rosalba Martines, Siegfried Kasper, Joseph Zohar, Alzbeta Juven-Wetzler, Daniel Souery, Stuart Montgomery, Julien Mendlewicz & Alessandro Serretti. (2017) Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance. European Archives of Psychiatry and Clinical Neuroscience 267:8, pages 723-735.
Crossref
měli bychom zhodnotit diagnostické aspekty & hlavně komorbiditu a adekvátnost dosavadní léčby včetně adherence.. (2016) Pharmacoresistant depression - what is the next step?. Psychiatrie pro praxi 17:3, pages 92-95.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.